18.06.2019 - US drugs giant Pfizer is digging into its deep pockets to boost its oncology portfolio. The New York-based company said it will pay $48 per share to acquire Array BioPharma, a US...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)